Back
Perspective Therapeutics Vs. Plus Therapeutics Industry Stock Comparison
Sell
30
CATX
Perspective Therapeutics
Last Price:
3.07
Seasonality Move:
27.93%
Sell
32
PSTV
Plus Therapeutics
Last Price:
1.08
Seasonality Move:
2.43%
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $3.07. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Plus Therapeutics (PSTV)
is a Sell
Is Plus Therapeutics a Buy, Sell or Hold?
- The current Plus Therapeutics [PSTV] share price is $1.07. The Score for PSTV is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- PSTV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $3.07
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
PSTV Stock Price Chart
What is Plus Therapeutics's stock price today?
-
The Plus Therapeutics share price today is $1.07
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PSTV is experiencing selling pressure, which indicates risk of future bearish movement.
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.53 | Sell |
Relative Strength Index (14 RSI): | 20.31 | Sell |
Chaikin Money Flow: | -1528174 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.76 - 7.16) | Sell |
Bollinger Bands (100): | (7.26 - 15.12) | Sell |
PSTV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 32.76 | Sell |
Chaikin Money Flow: | -170552 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.19 - 1.33) | Sell |
Bollinger Bands (100): | (1.26 - 1.56) | Sell |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.52 | Sell |
20-day SMA: | 3.98 | Sell |
50-day SMA: | 8.6 | Sell |
200-day SMA: | 12.31 | Sell |
8-day EMA: | 3.52 | Sell |
20-day EMA: | 4.66 | Sell |
50-day EMA: | 7.49 | Sell |
200-day EMA: | 10.23 | Sell |
PSTV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.28 | Sell |
20-day SMA: | 1.27 | Sell |
50-day SMA: | 1.31 | Sell |
200-day SMA: | 1.65 | Sell |
8-day EMA: | 1.24 | Sell |
20-day EMA: | 1.27 | Sell |
50-day EMA: | 1.32 | Sell |
200-day EMA: | 1.66 | Sell |
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.
Plus Therapeutics Earnings Growth & PSTV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.80 per share, and a decrease next year of $0.04 per share.
Perspective Therapeutics Technical Analysis
Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Plus Therapeutics Technical Analysis
Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |